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Dental management considerations for the patiens with diabtes mellitus
In oral surgery and pediatric dentistry
A review
Vullnet Fazliu 1 , Aferdita Gashi-Rizaj2

Abstract
The incidence of patients suffering from diabetes is increasing. Due to the increase in population, the
pediatric dentist as well as the oral surgeon must effectively treat the patients based on the protocol as
efficiently as possible.
Based on the review of various literature, the authors present relevant information about diabetes
mellitus, its type, manner of occurrence, complications, medical and dental management of these
patients.
There is a lot of medical and dental data which the pediatric dentist and the oral surgeon should take
into consideration when treating patients with diabetes mellitus.
Keywords: diabetes mellitus, oral surgery, pediatric dentistry
Introduction
Diabetes mellitus is a metabolic disease of glucose, fat, and protein that results from either impaired
insulin secretion, high insulin resistance, or both. This chronic disease is characterized by hyperglycemia
and complications including microvascular changes of the kidneys, eyes, and nervous system
(neuropathy). These complications are responsible for the high rate of mobility and mortality in the
diabetic population. (1)
In addition to these changes, oral manifestations are also evident, which also affects oral care.
Diabetes mellitus is classified as:
• Type 1 diabetes - insulin dependent: absolute lack of insulin due to autoimmune destruction or
accelerated destruction of pancreatic B cells, this is in fact inherited with a disorder of the genes on
chromosome 6.
• Type 2 diabetes - not insulin dependent: absolute lack of insulin or insulin resistance (inability to
produce insulin by the pancreas - resulting in lack of circulating insulin and consequently the appearance
of Diabetes Mellitus - Subsequent hyperglycemia).
Gestational : which occur in 5-7% of all pregnancies and result in loss of fetus. In case of surviving
fetuses,the usually overwiught .When pregnancy over,mother glycemic control return to normal but this
women are at developoing diabtetes in the next 5-10 years ,

Epidemiology
According to data from 2006, 23.6 million people (about 7.8% of the population) in the USA have been
diagnosed with diabetes, while now after this period of time, 34.2 million people have been diagnosed
with diabetes mellitus, meaning 1 in 10 people have diabetes mellitus, whereas 1 in 3 are prediabetic. The
increase in the number of young people 10-19 years diagnosed with diabetes mellitus is worrying. ( 2 )
Nearly 6 million people are not aware they have diabetes, and they only realize this after a complication
arises. The prevalence increases with age and about 245 million people are over the age of 60 years. An
epidemic of type 2 diabetes is almost on the rise knowing that globally the number of patients with type
2 diabetes is increasing year by year. Based on 150 - 220 million cases in 2010, this number is expected to
reach 300 million in 2025, which shows us that will cost a lot to treat DM, as well as this disease being a
clinical problem.

In addition, DM is considered to be the leading cause of blindness and kidney damage (in adults between
the ages of 20-74), gingivitis and periodontitis.
Also 1/3 of people with DM have severe periodontal disease, with loss of gingival connections to the teeth
on average 5mm-or more.
High morbidity with this disease, puts this disease among the 7 leading causes of death certified in the
USA in 2006. The risk of death in patients with DM is 2 times higher than in people without DM, of the
same ages.
Pathophysiology
Understanding the pathophysiology of diabetes still remains based on basic knowledge about
carbohydrate metabolism and insulin action. After consuming food, carbohydrates are broken down into
glucose molecules in the gut. Glucose is absorbed into the bloodstream, raising its level in the blood. This
increase in blood glucose stimulates the secretion of insulin by pancreatic β-cells. The insulin produced
binds to specific cellular receptors and enables the introduction of glucose into the cells, which enables
its use for energy as needed.
If the production and secretion of insulin changes, this is accompanied by a change in the dynamics of
glucose in the blood. If insulin production decreases, glucose uptake into cells is inhibited, resulting in
hyperglycemia. The same effect can be encountered if insulin is produced by the pancreas but not used
properly by the target cells. If the secretion of insulin increases, more glucose is stored in the cells, as a
result we have a small amount of glucose in the blood, which leads to hypoglycemia (3).
Cells store sufficient amounts of glucose. But if there is still a large amount of glucose in the blood, the
excess amount is stored in the liver, in the form of glycogen, which serves as a constant reservoir in the
future. When energy is needed, the glycogen stored in the liver by glycogenolysis is converted to glucose
as an energy source. But if the amount of glucose in the blood remains small even after glycogenolysis,
then the liver produces glucose from lipids (fatty acids) and proteins (amino acids), through the process
of glycogenesis. Thus, glycogenolysis and glycogenesis are processes that regulate the amount of glucose

in the blood. In this case the body must find an alternative way as an energy source, and in this case utilizes
triglycerides in fatty acids, this process is also known as gluconeogenesis, where in addition to glucose
production it also produces ketonic bodies that in a long period leads in diabetic ketoacidosis.
In addition, as a result of hyperglycemia, glucose is excreted through the kidneys and Polyuria (frequent
urination) occurs as a result of osmotic diuresis. Excessive fluid loss in this case leads the patient to
dehydration where the patient needs to drink as much fluid as possible (polydipsia). Also the lack of
glucose in the cells results in the patient starving (polyphagia), and all these consequences in the inability
to utilize glucose in the cells lead the patient to weight loss (depletion of fatty acid and protein reservoirs).
In addition to the hormone insulin which plays a key role in the regulation of carbohydrates in the blood,
other hormones such as: glucagon, catecholamines, growth hormones, thyroid hormones and
glucocorticoids. (4)

Etiology:
Diabetes mellitus can result in any of the following causes:
• genetic disorders - which attack both types of Diabetes, but mostly Type 2, because as a cause of Type
1 is mostly attributed to the role of viral infections and autoimmune reactions.
• primary disorders of pancreatic cells during inflammation, cancer, or surgery
• endocrine disorders such as hyperpituitarism or hyperthyroidism
• during other disorders in the body where the administration of high doses of steroids is required.

Complications of diabetes mellitus
Chronic increase in plasma glucose levels results in accumulation of glucose and extracellular metabolic
products, and as a result then we also have complications which are:
Acute complications
- Ketoacidosis
- Non-ketotic hyperosmolar hyperglycemic syndrome
- Hypoglycemia
Chronic Complications
• microvascular changes in the eye (retinopathy- microaneurysm of the retina)
• kidney (nephropathy), and
• neuropathy.
Macrovascular changes

Ulcers on foot.
In the group of patients with poor diabetic controls, it is more important that in these cases the
prolongation of wound healing after surgical-oral and pediatric interventions may appear and as a result
it may increase the chances for postoperative infections.
Also special attention should be paid to the non-enzymatic process Glycation - (binding of glucose to
proteins and fats) which results in the release of Piole products - Sorbitol or Mannitol which are metabolic
products of glucose that also cause tissue damage. (6)
Diabetes and manifestations in the oral cavity
The manifestation of diabetes is also encountered in the oral cavity. Xerostomia as a symptom of diabetes
in the mouth, leads to dry surfaces of the mouth and as a result burns off the oral mucosa, as well as
creating a suitable environment for the development of candidiasis or bacterial infections.
In addition to the above, according to numerous studies, the reason that leads to a high incidence of
infections either before or after certain surgical interventions is attributed to the fact that the defense
mechanisms are severely impaired starting from deficient vascularization, reduction of production of
growth factors, reduced immunity as well as psychological stress. All these then affect the prolongation
of processes such as those of regenerative oral soft tissue or bone healing processes (7).
The effect of diabetes on the appearance of caries is still unclear, although some studies suggest that
xerostomia and increased glucose in the gingival fluid, creates the possibility of the appearance of caries.
But, knowing that patients with diabetes have limited intake of fermented carbohydrates, the studies
between patients with type II diabetes and the control group, show that there are no significant
differences regarding the increased incidence of caries with 2 groups. Data in Sweden also shows that the
percentage of the population affected by gingivitis and moderate periodontitis has decreased and the
percentage of the population with healthy peridoncium has increased, all as a result of diabetes and oral
health management. For example, this percentage of healthy periodontium was for 1983-23%, in 199322% and in 2003-44%.
Diabetes and periodontium
Diabetes and periodontal disease are the two most common chronic diseases in some parts of the world.
Research shows that there is a two-way relationship between diabetes and periodontal disease, so that
diabetes endangers periodontal health due to poor glucose control, which leads to periodontal disease,
which also worsens diabetes. This shows how important it is not only for oral health professionals, but for
all health professionals, to understand the role and importance of oral health management in patients
with diabetes. We will focus on some key objectives, based on research done on diabetes and periodontal
disease, such as:
1-The negative effect that diabetes has on periodontal health,
2-Negative effect of periodontal infection on glucose control in diabetes and
3-Periodontal infection and the development of complications in diabetes, but also the impact on the
pathogenesis of diabetes itself (8).

The negative effect of diabetes on periodontal health
It is known that diabetes affects periodontal diseases, but that it also depends on the controls against
diabetes. Patients who have good control over diabetes show the same degree of gingivitis compared to
healthy people. Although numerous epidemiological studies suggest impairment of ligaments in the
periodontium and bone resorption, almost 3 times more than in people without diabetes. Also patients
with diabetes easily develop periodontal disease as a complication of diabetes, if they do not take care of
oral hygiene, always knowing that dental plaque is the main cause of periodontal diseases. But in patients
with well-managed diabetes and careful oral health care there are no significant differences with
incidence of periodontal disease in healthy individuals.
Hyperglycemia encountered in the blood will be found increased in the gingival fluid and this leads to
vascular changes in the gingiva, as well as other complications in the retina, kidneys, etc. Atherosclerotic
changes lead to narrowing of blood vessels, resulting in increased periodontal tissue destruction and poor
reparative potential. (10)
Diabetes also damages immune cells, such as polymorphonuclear leukocytes, monocytes, and
macrophages, impairing polymorphonuclear adhesion, chemotaxis, and phagocytosis. This leads to
increased inflammation in the periodontal epithelium and connective tissue, increasing the degradation
of tissue connections and bone loss because bacterial agents act freely.
Collagen, as the primary structural protein in the periodontium, is also damaged. This is because it
increases the production of collagenase, a collagen-destroying enzyme that continuously destroys the
collagen produced. Thus, diabetes affects the normal synthesis of collagen, and consequently the difficult
healing of wounds.
Tetracycline agents reduce collagen production and collagen degradation by antimicrobial action,
therefore indicated for the treatment of periodontitis, arthritis, diabetes, osteoporosis, etc. (11)

The negative effect of periodontal infection on glucose control in diabetes
The data show that periodontal infection can affect glycemic control of diabetes, because periodontal
infection increases the risk for minimal control against glycemia, especially in cases with complications of
diabetes, such as nephropathy and macrovascular disease. In one study, 82% of patients with advanced
diabetes and periodontitis had a cardiovascular, cerebrovascular, or peripheral vascular attack during the
1-11 years of the study, compared with only 21% of individuals with milder-grade diabetes. low or no
periodontal disease. (12).
In patients with diabetes, periodontal treatment has an effect on glycemic control. Studies have confirmed
this in patients with diabetes and periodontal tissue treatment with combination therapy with tetracycline
(doxycycline), but not in patients treated with periodontitis but without antibiotics.
The mechanism by which antibiotics, together with periodontal treatment, have a positive effect on
glycemic control is not yet known. Perhaps this is because subgingival pathogens are eliminated and
collagen production is suppressed, which destroys collagen.

Oral manifestations that occur in diabetic patients are
Gingival and periodontal pathologies
Prevalence / assessment in the progression of oral changes, accurate instructions for oral hygiene, dietary
instructions, frequent periodic examinations, and prophylaxis.
Salivary gland dysfunctions and xerostomia / caries, mucosa, absence of papillae.
Prevalence / mouthwash Rich in fluoride as well as saliva substitutes (xylitol-carboxymethylcellulose
- or hydroxyl cellulose, stimulating muscle receptors. (13)

Medical treatment and dental treatment of patients who undergo surgeries in oral surgery and
pedodontics.
The main purpose of treating patients with DM is to keep blood glucose levels as normal as possible, and
this is achieved by controlling glucose which also prevents concomitant complications.
Normal blood glucose values;
Beetwen 4.0 -5.4 mmol / l (72-99mh.Dl),

Up to 7.8 mmol / L (140 mg / Dl) 2 hours after meals

For diabetic patients, the target values should be:
Before meals: 4-7 mmol / type 1 and 2

After feeding: below 9 mmol / L for Type 1 and 8.5 mmol / L for Type 2.

According to the American Diabetes Association, it is recommended that people over the age of 45 have
a diabetes test every 3 years.
As glucose circulates in the blood, it attaches to a portion of the hemoglobin molecule in the erythrocytes,
and as blood glucose rises, so does the percentage of hemoglobin that binds to glucose. There are 2 tests
that measure glucose hemoglobin:
1. Hemoglobin A1 (HbA1), normal value is less than 8% and
2. Hemoglobin A1c (HbA1c), normal value is 6.0-6.5%.
The other method for measuring blood glucose levels is the fructosamine test, where normal values range
from 2.0-2.8mmol / L and measures glucose in the next 2-4 weeks.
Glucose monitoring is also performed by the patient himself, with the help of glucometers. Patients with
type I diabetes measure their blood glucose level several times a day, compared to patients with type II
diabetes. (14)

The target values to be achieved in diabetic patients are:
Target values: HbA1C
≤7.0%

Pre-meal value of blood glucose mmol / L
4.0-7.0

2 h after meal mmol / L
5.0-10.0

Drug management
The main goal of medical management in all diabetic patients is to keep blood glucose levels as normal
as possible.
As a medication for the treatment of Diabetes is Insulin which is administered either subcutaneously or
per os .
Insulin - which is used to treat patients with diabetes is found in several forms, based on the time of action:
Rapid - reacts within 15 min. with the highest point of activity in 45-90min
Short action - reacts within 30 min. With the highest point of activity in 2-5 h
Intermediate action (lens) - reacts within 1-2 h, with the highest point of activity 6-12h
Long action (Ultralente) - reacts within 4-6 h, with the highest point of activity 8-20 h. (15)
In cases of type 1 diabetes, due to the correlation between suboptimal glucose control and vascular
complications, intensive management is the main way recommended to all patients. This is actually
achieved even through more frequent insulin administration (up to 4 times a day) or the use of different
types of insulin as well as the monitoring of blood glucose.
Insulin administration should be done individually, adapting to each patient separately, age and lifestyle.
For example, adults and adolescents are given intermediate-acting insulin at bedtime, school-age children
are given short-acting insulin, and give a glass of tea in the afternoon instead of lunch to prevent
hyperglycemia, while preschool children may be given manage a dose of intermediate-acting insulin in
the morning and small doses of fast-acting insulin analogues to prevent hyperglycemia later.

In order to minimize the risk of any intraoperative emergency, clinicians need to correctly apply
management protocols based on a few points:
Medical history
Have a clear glucose value before each treatment, as well as previous glucose values or any previous
hypoglycemic condition.

We should also be informed about antidiabetic medications, the dose and time at which they are
administered. In addition, we should be informed about medications that may interfere with blood
glucose levels either in the role of insulin or in carbohydrate metabolism.
Drugs that have hypoglycemic action - salicylates, dicumerol, b-adrenergic blockers, sulfanamides or even
angiotensin inhibitory converting enzymes. (16)
While drugs with hyperglycemic action are: corticosteroids, epinephrine, oral contraceptives or calcium
channel blocker drugs.

Scheduling an appointment for a medical visit
Generally, morning visits are recommended because the level of endogenous cortisol in this daily period
is high (the role of cortisol - increases the level of glucose in the blood), also patients should definitely
take the daily dose of insulin since in the morning its peak of action is low and thus prevents the
occurrence of any eventual state of Hypoglycemia. (17)

Diet:
It is much more important for clinicians to make sure that the patient has eaten breakfast and has received
the necessary therapy (insulin). On the contrary if the patient has not eaten breakfast but has taken a
certain dose of insulin then he is at risk for a hypoglycemic crisis.
In cases when it is necessary to make major interventions under sedation or anesthesia, food should be
avoided before this procedure, the insulin dose should be modified in consultation with the specialist
doctor who is checking the patient (18).

Blood glucose monitoring:
Depending on the medical history, therapy or even the procedures that need to be performed, dentists
need to measure the level of glucose in the blood.
If the blood glucose level is less than 70 mg / Dl, then we should prescribe sugars before the intervention
in order to minimize the hypoglycemic crisis. While in patients when the blood glucose level is too high,
then in we refer the patient to make a consultation with the specialist doctor before treatment. (19)

Management during treatment
The critical condition that may occur during the treatment of patients with Diabetes Mellitus is the
hypoglycemic crisis. This is when insulin levels exceed physiological needs, and usually occur when the
effect of insulin is maximal.
The initial clinical signs during a hypoglycemic episode are:
Mood swings, weakness, and then accompanied by sweating, tachycardia, and if we do not react
immediately the patient may experience consciousness, hypotension, hypothermia, fever, coma and
eventually death. (20)
How to manage: To stop the intervention, then to administer 15 g of glucose or any glucose tablet,
chocolate, but in cases when the patient has already lost consciousness then administer intravenously25
-30 mL of 50% dextrose solution or 1mg of glucagon ( it can also be administered subcutaneously or
intravenously) ( 21 )
If the long period of hyperglycemia persists, then ketoacidosis appears when the patient clinically results
in theft, loss of concentration, abdominal pain and bad acetone odor. In these cases, insulin administration
is required.(22)

Intraoperative management of hypoglycemic emergency
Signs and Symptoms Managing emergencies

Mild
•

hunger

•

fatigue

•

sweating

•

nausea

•

abdominal
pain

•

headache

•

tachycardia

•

irritability

Moderate
•

incoherence

•

uncooperative

•

belligerence

•

resistive
behaviour

•

Terminate dental treatment immediately

Awake/alert patient
•

Administer 15 g oral carbohydrate (i.e., glucose tablet, 180 mL
orange juice, 15–25 mL sugar)

•

Monitor blood glucose and repeat carbohydrate dosing as
necessary

Uncooperative patient
•

Seek emergency medical assistance

•

Administer glucagon 1 mg via subcutaneous or intramuscular
injection followed by oral glucose supplement or

•

Administer 20–50 mL of 50% dextrose solution intravenously

Unconscious patient
•

Seek emergency medical assistance

•

Administer 20–50 mL of 50% dextrose solution

Severe
•

unconscious

•

seizure

After treatment
Clinicians should also consider possible postoperative changes in this group of patients.

In the case of the group of patients with poor control of Diabetes Mellitus are more at risk of developing
infection and wound healing, therefore if we are dealing with major surgical interventions then we must
take certain doses of antibiotics for preventive.
Also patients who use drugs such as salicylates increase insulin secretion and as a result may lead to
hypoglycemia. Therefore, aspirin should be avoided in the postoperative period.
As a conclusion in the context of dental management we need to take the following steps:
- Consultation with a specialist doctor regarding diabetes
- To receive an accurate medical history including medications which are under the prescription of the
patient
- To be confirmed by the patient who has eaten food and taken medication before treatment
- The pedodontist or oral surgeon should be aware of the emergency symptoms of diabetes and how to
manage that emergency condition
- Prevention, treatment and elimination of infections in advance
- Do not use aspirin
- Achieve deep local anesthesia (to reduce stress)
- Ensure good oral hygiene
- Provide a regular diet and medication
- Provide a glucometer when we have conservative treatment or oral surgery. (23)

Conclusion
Based on the fact that now with about 318 million people worldwide suffer from Diabetes, it is clear that
Oral Surgeons or Pediatric Dentist during their professional careers with treat such patients suffering from
this chronic disease, add here the number of oral manifestations and the risk of intraoperative
emergencies, it is necessary for us to have the knowledge about the underlying disease, the consequences
that appear from this disease which result in the oral cavity and to have accurate knowledge about how
to treat these manifestations, and as a professional doctor to cooperate together so as to effectively inform
the patient about exemplary oral health care.
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